Page 370 - Read Online

Gururangan et al. Neuroimmunol Neuroinflammation 2018;5:45 I http://dx.doi.org/10.20517/2347-8659.2018.44 Page 15 of 15

100. Wildes TJ, Grippin A, Dyson KA, Wummer BM, Damiani DJ, et al. Cross-talk between T cells and hematopoietic stem cells during
adoptive cellular therapy for malignant glioma. Clin Cancer Res 2018;24:3955-66.
101. Heimberger AB, Crotty LE, Archer GE, McLendon RE, Friedman A, et al. Bone marrow-derived dendritic cells pulsed with tumor
homogenate induce immunity against syngeneic intracerebral glioma. J Neuroimmunol 2000;103:16-25.
102. Liau LM, Black KL, Prins RM, Sykes SN, DiPatre PL, et al. Treatment of intracranial gliomas with bone marrow-derived dendritic cells
pulsed with tumor antigens. J Neurosurg 1999;90:1115-24.
103. Heimberger AB, Archer GE, Crotty LE, McLendon RE, Friedman AH, et al. Dendritic cells pulsed with a tumor-specific peptide induce
long-lasting immunity and are effective against murine intracerebral melanoma. Neurosurgery 2002;50:158-64.
104. Gururangan S, Grant G, Driscoll T, Archer G, Herndon J, et al. IMMU-27. Re-MATCH protocol: phase I study of autologous tumor
specific lymphocyte transfer (ALT) + DC vaccine (DCV) during recovery from myeloablative chemotherapy (MAC) and autologous
stem cell rescue (HDC + ASCR) or non-myeloablative chemotherapy (NMAC) in patients with recurrent central PNETs (r-PNETs).
Neuro Oncol 2018;20:i104.
105. Rausch T, Jones DT, Zapatka M, Stütz AM, Zichner T, et al. Genome sequencing of pediatric medulloblastoma links catastrophic DNA
rearrangements with TP53 mutations. Cell 2012;148:59-71.
106. Ishihara D, Pop L, Takeshima T, Iyengar P, Hannan R. Rationale and evidence to combine radiation therapy and immunotherapy for
cancer treatment. Cancer Immunol Immunother 2017;66:281-98.
107. Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, et al. Commensal Bifidobacterium promotes antitumor immunity and
facilitates anti-PD-L1 efficacy. Science 2015;350:1084-9.
108. Pitt JM, Vétizou M, Gomperts Boneca I, Lepage P, Chamaillard M, et al. Enhancing the clinical coverage and anticancer efficacy of
immune checkpoint blockade through manipulation of the gut microbiota. Oncoimmunology 2016;6:e1132137.
109. Sayour EJ, De Leon G, Pham C, Grippin A, Kemeny H, et al. Systemic activation of antigen-presenting cells via RNA-loaded
nanoparticles. Oncoimmunology 2016;6:e1256527.
110. Neagu MR, Reardon DA. An update on the role of immunotherapy and vaccine strategies for primary brain tumors. Curr Treat Options
Oncol 2015;16:54.